Liposome-coated CaO2 nanoblockers for enhanced checkpoint blockade therapy by inhibiting PD-L1 de novo biosynthesis

The blocking of the immune checkpoint pathway with antibodies, especially targeting to programmed death-1/programmed death ligand-1 (PD-1/PD-L1) pathway, was currently a widely used treatment strategy in clinical practice. However, the shortcomings of PD-L1 antibodies were constantly exposed with th...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nano research 2023-05, Vol.16 (5), p.7227-7236
Hauptverfasser: Che, Ruijun, Han, Dandan, Wang, Fei, Liu, Huifang, Fan, Miao, Yan, Hongyu, Xiao, Tingshan, Wang, Zhaoshuo, Zhou, Xiaohan, Wang, Xueyi, Zhang, Kaihan, Ou, Caiwen, Zhang, Jinchao, Li, Zhenhua
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!